Credit Suisse plans Bares linked to iShares Nasdaq Biotechnology ETF

By Marisa Wong

Morgantown, W.Va., June 12 – Credit Suisse AG, London Branch plans to price 0% Buffered Accelerated Return Equity Securities due June 18, 2020 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

If the ETF return is positive, the payout at maturity will be par plus 150% of the ETF return, subject to a maximum return that is expected to be 35.5% to 37.5%. Investors will receive par if the ETF falls by up to 20% and lose 1.25% for every 1% decline in the ETF beyond 20%.

Credit Suisse Securities (USA) LLC is the underwriter.

The notes will price on June 14.

The Cusip number is 22550BAU7.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.